company background image
AGP

AGP KASE:AGP Stock Report

Last Price

PK₨77.00

Market Cap

PK₨21.6b

7D

3.4%

1Y

-39.9%

Updated

27 Sep, 2022

Data

Company Financials +
AGP fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance2/6
Financial Health6/6
Dividends1/6

AGP Stock Overview

AGP Limited manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products under licensing arrangements in Pakistan.

AGP Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for AGP
Historical stock prices
Current Share PricePK₨77.00
52 Week HighPK₨129.60
52 Week LowPK₨72.00
Beta0.77
1 Month Change-6.38%
3 Month Change-11.71%
1 Year Change-39.89%
3 Year Change19.38%
5 Year Changen/a
Change since IPO-8.33%

Recent News & Updates

Shareholder Returns

AGPPK PharmaceuticalsPK Market
7D3.4%0.2%0.7%
1Y-39.9%-26.3%-14.1%

Return vs Industry: AGP underperformed the PK Pharmaceuticals industry which returned -25.8% over the past year.

Return vs Market: AGP underperformed the PK Market which returned -14.2% over the past year.

Price Volatility

Is AGP's price volatile compared to industry and market?
AGP volatility
AGP Average Weekly Movement3.4%
Pharmaceuticals Industry Average Movement3.4%
Market Average Movement4.9%
10% most volatile stocks in PK Market7.8%
10% least volatile stocks in PK Market3.2%

Stable Share Price: AGP is less volatile than 75% of PK stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: AGP's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19891,151Nusrat Munshihttps://www.agp.com.pk

AGP Limited manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products under licensing arrangements in Pakistan. The company offers products in the areas of aminoglycosides, angiotensin II antagonist, anti epileptics, anti-gout, anti-infective antidiarrheal, anti-inflammatory enzyme, antidiarrheal microorganisms, antifibrinolytic, antihistamines systemic, antileuk anti-ashtm sys, antineoplastic agent, anti-obesity, antirheumatic non-steroid, antispasmodic and anticholinergic plain, biguanide and S-urea combs, bile stone therapy, calcium, calcium channel blocker, cephalosporins oral and inject, DPP-IV Inh and biguanide comb, DPP-IV Inh A-diab plain, expectorants, eye tonics and eye vitamins, fluoroquinolones, glitazone and biguanide combinations, hepatitis C antivirals, iron combination products, muscle relaxants central, narcotic analgesic, and non-narcotic analgesic. It also provides SGLT2 inhibitors antidiabetic and biguanide, psycholeptic antidepressant, nucleoside reverse transcriptase inhibitors, Oth folic acid, stomach disorder products, proton pump inhibitor, SSRI antidepressants, sulphonylurea, systemic vasoprotectives, tonic, topical antihaemorrhoidal, urinary anti-infectives, urinary incontinence prd, vitamin B12, vitamin D3, and xanthine-systemic products.

AGP Limited Fundamentals Summary

How do AGP's earnings and revenue compare to its market cap?
AGP fundamental statistics
Market CapPK₨21.56b
Earnings (TTM)PK₨1.77b
Revenue (TTM)PK₨12.79b

12.2x

P/E Ratio

1.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
AGP income statement (TTM)
RevenuePK₨12.79b
Cost of RevenuePK₨6.12b
Gross ProfitPK₨6.68b
Other ExpensesPK₨4.91b
EarningsPK₨1.77b

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)6.30
Gross Margin52.19%
Net Profit Margin13.79%
Debt/Equity Ratio37.2%

How did AGP perform over the long term?

See historical performance and comparison

Dividends

3.2%

Current Dividend Yield

40%

Payout Ratio